Artwork

เนื้อหาจัดทำโดย Deborah Roberts เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Deborah Roberts หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Player FM - แอป Podcast
ออฟไลน์ด้วยแอป Player FM !

1.5 - Dr Reid Robison: Undoing Rigid Thinking

48:45
 
แบ่งปัน
 

Manage episode 287770142 series 2896878
เนื้อหาจัดทำโดย Deborah Roberts เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Deborah Roberts หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal

Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher.


Reid has led over 100 clinical trials in neuropsychiatry. He completed his undergraduate in Neuroscience at Brigham Young University and went on to medical school at the University of Utah where he earned both his MD and MBA. Of course, he didn’t stop there, after residency training in Psychiatry, Dr Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics.


As an early adopter and researcher of Ketamine in psychiatry, Reid obtained his first grant to study ketamine in 2011. He also led the Utah site for the pivotal ketamine study for TRMDD by Janssen, leading up to the company’s recent FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions.


Reid has built a number of therapeutic-driven companies including Tute Genomics, a venture-backed personalized medicine startup that was acquired in 2016, Cedar Psychiatry, which he co founded and serves as a Medical Director of Center for Change, a top Eating Disorder program. He is also a founding board member at the Utah-based non-profit organisation Psychedelic Institute. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad, and is the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders.


In this episode:

  • Mental health crisis
  • Epigenetics and genetics in mental health conditions
  • Resetting and opening up new neural pathways
  • Neuroscience of ketamine
  • Pharmacogenetics

Links:

Novamind

Cedar Psychiatry


Support the podcast:

Support the podcast (Patreon)


Support the mission:

Mind Medicine Australia

Donate to Mind Medicine Australia

Join a local chapter


Support this show http://supporter.acast.com/mind-medicine-australia.

Become a member at https://plus.acast.com/s/mind-medicine-australia.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

41 ตอน

Artwork
iconแบ่งปัน
 
Manage episode 287770142 series 2896878
เนื้อหาจัดทำโดย Deborah Roberts เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Deborah Roberts หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal

Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher.


Reid has led over 100 clinical trials in neuropsychiatry. He completed his undergraduate in Neuroscience at Brigham Young University and went on to medical school at the University of Utah where he earned both his MD and MBA. Of course, he didn’t stop there, after residency training in Psychiatry, Dr Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics.


As an early adopter and researcher of Ketamine in psychiatry, Reid obtained his first grant to study ketamine in 2011. He also led the Utah site for the pivotal ketamine study for TRMDD by Janssen, leading up to the company’s recent FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions.


Reid has built a number of therapeutic-driven companies including Tute Genomics, a venture-backed personalized medicine startup that was acquired in 2016, Cedar Psychiatry, which he co founded and serves as a Medical Director of Center for Change, a top Eating Disorder program. He is also a founding board member at the Utah-based non-profit organisation Psychedelic Institute. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad, and is the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders.


In this episode:

  • Mental health crisis
  • Epigenetics and genetics in mental health conditions
  • Resetting and opening up new neural pathways
  • Neuroscience of ketamine
  • Pharmacogenetics

Links:

Novamind

Cedar Psychiatry


Support the podcast:

Support the podcast (Patreon)


Support the mission:

Mind Medicine Australia

Donate to Mind Medicine Australia

Join a local chapter


Support this show http://supporter.acast.com/mind-medicine-australia.

Become a member at https://plus.acast.com/s/mind-medicine-australia.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

41 ตอน

ทุกตอน

×
 
Loading …

ขอต้อนรับสู่ Player FM!

Player FM กำลังหาเว็บ

 

คู่มืออ้างอิงด่วน